功能性便秘的微生物群治疗:现状和未来前景
Yan Li1, Xiao-Han Zhang1,2, Zi-Kai Wang1,3
1Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
World journal of hepatology
|May 31, 2024
概括
功能性便秘 (FC) 治疗需要安全,有效的选择. 微生物群治疗,包括益生菌和便微生物群移植 (FMT),显示出对管理这种常见疾病的希望.
科学领域:
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
- 治疗创新 治疗创新
背景情况:
- 功能性便秘 (FC) 是一种普遍存在的胃肠道疾病,导致难以和不经常排便.
- 肺结核严重影响患者的生活质量,需要长期治疗解决方案.
- 目前对FC的治疗策略需要进一步开发,以确保安全性和有效性.
研究的目的:
- 探索基于微生物群的功能性便秘治疗方法的潜力.
- 审查各种微生物群调节剂及其在FC管理中的现状.
- 突出便微生物群移植 (FMT) 在治疗FC中的新兴作用.
主要方法:
- 对功能性便秘的微生物群调节器现有文献的审查.
- 分析益生菌,益生菌,共生菌,后生菌和FMT的疗效和应用.
- 评估这些疗法目前的研究和临床实施阶段.
主要成果:
- 益生菌和益生菌是FC的微生物群调节剂.
- 其他调节剂,如共生菌和后生菌正在调查中.
- 便微生物群移植 (FMT) 显示出治愈潜力,但需要进一步研究临床使用.
结论:
- 基于微生物群的疗法为管理功能性便秘提供了一个有希望的途径.
- 进一步的研究对于确定新兴微生物群治疗方法的安全性和有效性至关重要,特别是FMT.
- 优化微生物群调节策略可能会改善FC患者的长期结果.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
157
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157
Bacterial Flora of the Large Intestine
421
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
421
Drugs for Treatment of Diarrhea-Predominant IBS
159
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159
Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139
Irritable Bowel Syndrome III: Medical and Nursing Management
195
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
195
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331


